Personalized medicine against cancer
Multimedia version
with audio image gallery and animated graphics
Economic data
The Boston Consulting Group report "“Medical Biotechnology in Germany 2011" deals with economic data and the benefits of personalized medicine.
Global cancer database
The International Agency for Research on Cancer, part of the World Health Organization (WHO), has collected prevalence and mortality figures for various types of cancer in its global cancer database, GLOBOCAN 2008.
Personalized Medicine Coalition
The Personalized Medicine Coalition, a group of pharmaceutical, biotechnology, diagnostics and IT companies, academic institutions and government agencies, promotes the debate on the implementation of personalized medicine.
Medicines
An overview of available drugs and their biomarker tests is available at:
Diagnostic tests
Alberto Gutierrez, Director of the Office of In Vitro Diagnostics at the U.S. Food and Drug Administration, talks in an interview on diagnostic tests and personalized medicine.
Genetic variations
A detailed report from the U.S. National Institutes of Health, also on personalized medicine.
Biomarkers
The National Institute of Environmental Health Sciences, U.S. National Institutes of Health, provides information about biomarkers and their significance for personalized medicine.
Innovative Medicines Initiative
Europe's largest public-private partnership in the field of medicine, with videos and other information about advances and current projects.
Colon cancer
A compilation by the U.S. National Cancer Institute provides information about the treatment of colon cancer.
Singapur Biopolis
Two videos provide information about the concept behind the biomedical research center.
Cancer research in Singapore
The Cancer Science Institute (CSI) Singapore provides an insight into its work.
Bayer cooperation partners
The Director of the Investigational Medicine Unit (IMU) of the National University Health System (NUHS), Singapore, is one of Bayer's cooperation partners.